VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RNXT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RNXTRenovoRx, Inc.
$0.93$35M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRNXTQuarterly Financials

RenovoRx, Inc. (RNXT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

RenovoRx, Inc. (RNXT) quarterly income statement — complete revenue, gross profit & net income history

RNXT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue563K238K266K422K197K43K00000000000000
Revenue Growth %185.79%453.49%------------------
Cost of Goods Sold84K28K53K152K94K000000000000000
COGS % of Revenue14.92%11.76%19.92%36.02%47.72%---------------
Gross Profit479K210K213K270K103K43K00000000000000
Gross Margin %85.08%88.24%80.08%63.98%52.28%100%--------------
Gross Profit Growth %365.05%388.37%------------------
Operating Expenses3.95M3.73M3.41M2.95M3.21M2.67M2.83M3.03M2.48M1.78M2.98M3.38M3.26M2.17M2.16M2.61M3M2.36M1.4M866K
OpEx % of Revenue701.24%1568.49%1283.08%698.58%1630.96%6220.93%--------------
Selling, General & Admin2.72M2.23M1.73M1.52M1.57M1.1M1.18M1.49M1.22M1M1.35M1.45M1.92M1.39M1.31M1.22M1.72M1.25M628K330K
SG&A % of Revenue483.13%937.82%649.62%360.66%797.46%2555.81%--------------
Research & Development1.23M1.5M1.69M1.43M1.64M1.58M1.65M1.54M1.26M775K1.63M1.93M1.34M776K846K1.39M1.29M1.1M767K536K
R&D % of Revenue218.12%630.67%633.46%337.91%833.5%3665.12%--------------
Other Operating Expenses00000000000000000000
Operating Income-3.47M-3.52M-3.2M-2.68M-3.11M-2.63M-2.83M-3.03M-2.48M-1.78M-2.98M-3.38M-3.26M-2.17M-2.16M-2.61M-3M-2.36M-1.4M-866K
Operating Margin %-616.16%-1480.25%-1203.01%-634.6%-1578.68%-6120.93%--------------
Operating Income Growth %-11.54%-33.85%-13.15%11.73%-25.61%-48.11%5.2%10.1%24.07%18.11%-38.04%-29.11%-8.52%7.89%-54.91%-201.85%-185.38%-268.7%--
EBITDA-3.47M-3.52M-3.2M-2.68M-3.11M0-2.83M-3.03M-2.48M-1.78M-2.98M-3.37M-3.26M-2.17M-2.16M-2.61M-3M-2.35M-1.39M0
EBITDA Margin %-616.16%-1479.83%-1203.38%-634.36%-1578.17%---------------
EBITDA Growth %-11.58%--13.19%11.77%-25.57%100%5.15%10.06%24.07%18.18%-37.97%-29.2%-8.63%7.74%-55.47%--185.09%---
D&A (Non-Cash Add-back)01K-1K1K1K2.63M0001.5K1.5K1.5K0003K3K4K5K866K
EBIT-3.47M-3.52M-3.2M-2.68M-2.42M-2.63M-2.83M-3.03M-2.48M-1.78M-2.98M-3.38M-3.26M-2.17M-2.16M-2.61M-3M-2.36M-1.4M-866K
Net Interest Income45K75K113K133K106K85K124K138K37K043K50K4K14K22K20K1K1K-208K-397K
Interest Income45K75K113K133K106K85K124K138K37K043K50K4K14K22K20K1K1K00
Interest Expense00000000000000000-208K397K
Other Income/Expense-52K581K288K-217K690K-246K357K645K1.4M-1.45M1.56M1.05M4K14K25K20K2K1K-116K-444K
Pretax Income-3.52M-2.94M-2.91M-2.9M-2.42M-2.88M-2.47M-2.39M-1.08M-3.23M-1.42M-2.33M-3.26M-2.16M-2.14M-2.59M-3M-2.35M-1.51M-1.31M
Pretax Margin %-625.4%-1236.13%-1094.74%-686.02%-1228.43%-6693.02%--------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-3.52M-2.94M-2.91M-2.9M-2.42M-2.88M-2.47M-2.39M-1.08M-3.23M-1.42M-2.33M-3.26M-2.16M-2.14M-2.59M-3M-2.35M-1.51M-1.31M
Net Margin %-625.4%-1235.71%-1094.74%-686.02%-1228.43%-6693.02%--------------
Net Income Growth %-45.5%-2.19%-17.85%-21.18%-124.91%10.81%-73.89%-2.66%66.96%-49.68%33.47%10.29%-8.46%8.45%-41.36%-98.02%-161.59%-168.22%--
Net Income (Continuing)-3.52M-2.94M-2.91M-2.9M-2.42M-2.88M-2.47M-2.39M-1.08M-3.23M-1.42M-2.33M-3.26M-2.16M-2.14M-2.59M-3M-2.35M-1.51M-1.31M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.09-0.08-0.08-0.08-0.08-0.13-0.10-0.10-0.04-0.15-0.07-0.11-0.18-0.11-0.12-0.14-0.17-0.21-0.13-0.08
EPS Growth %-20.1%35.62%19.27%20.24%-114.17%13.33%-49.25%9.73%80%-36.36%44.67%21.43%-5.88%47.62%7.69%-75.44%-148.18%-307.77%--
EPS (Basic)-0.09-0.08-0.08-0.08-0.08-0.13-0.10-0.10-0.04-0.15-0.07-0.11-0.18-0.11-0.12-0.14-0.17-0.21-0.13-0.08
Diluted Shares Outstanding38.03M35.33M36.65M36.58M31.4M22.27M24.94M24.05M29.89M21.39M21.39M21.31M18.18M18.19M18.14M18.11M17.98M11.24M11.24M16.42M
Basic Shares Outstanding38.03M35.33M36.65M36.58M31.4M22.27M24.94M24.05M29.89M21.39M21.39M21.31M18.18M18.19M18.14M18.11M17.98M11.24M11.24M16.42M
Dividend Payout Ratio--------------------